Clozapine blood monitoring can now be reduced to every 12 weeks after 1 year of treatment, and annually after 2 years, in patients without neutropenia.

Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in ...

VANCOUVER, British Columbia, July 14, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the“Company”), a leader in pharmaceutical-grade cannabis ...